{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:34:03Z","timestamp":1790278443540,"version":"4.1.0"},"reference-count":179,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T00:00:00Z","timestamp":1572652800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"FWO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["OT\/14\/101"],"award-info":[{"award-number":["OT\/14\/101"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Interuniversity Attraction Poles Programme"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.bbamcr.2018.06.004","type":"journal-article","created":{"date-parts":[[2018,6,13]],"date-time":"2018-06-13T00:25:40Z","timestamp":1528849540000},"page":"1707-1717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"PB","title":["Pathophysiological consequences of isoform-specific IP3 receptor mutations"],"prefix":"10.1016","volume":"1865","author":[{"given":"Martijn","family":"Kerkhofs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Seitaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hristina","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Monaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Bultynck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan B.","family":"Parys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamcr.2018.06.004_bb0005","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.cell.2007.11.028","article-title":"Calcium signaling","volume":"131","author":"Clapham","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0010","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006767","article-title":"Ca2+ signaling during mammalian fertilization: requirements, players, and adaptations","volume":"3","author":"Wakai","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0015","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1124\/mol.116.105171","article-title":"Modulation of autophagy by calcium signalosome in human disease","volume":"90","author":"Filippi-Chiela","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/35036035","article-title":"The versatility and universality of calcium signalling","volume":"1","author":"Berridge","year":"2000","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1152\/physrev.00023.2005","article-title":"Calcium at fertilization and in early development","volume":"86","author":"Whitaker","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0030","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-94-007-2888-2_11","article-title":"Inositol 1,4,5-trisphosphate and its receptors","volume":"740","author":"Parys","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0035","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jbior.2014.10.001","article-title":"Role of IP3 receptor signaling in cell functions and diseases","volume":"57","author":"Mikoshiba","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0040","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/j.bbamcr.2014.03.007","article-title":"Inositol 1,4,5-trisphosphate receptor-isoform diversity in cell death and survival","volume":"1843","author":"Ivanova","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0045","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a003996","article-title":"Ryanodine receptors: structure, expression, molecular details, and function in calcium release","volume":"2","author":"Lanner","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0050","doi-asserted-by":"crossref","first-page":"21691","DOI":"10.1016\/S0021-9258(17)31861-6","article-title":"Determination of relative amounts of inositol trisphosphate receptor mRNA isoforms by ratio polymerase chain reaction","volume":"269","author":"De Smedt","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0055","doi-asserted-by":"crossref","first-page":"11678","DOI":"10.1074\/jbc.270.19.11678","article-title":"Type I, II, and III inositol 1,4,5-trisphosphate receptors are unequally susceptible to down-regulation and are expressed in markedly different proportions in different cell types","volume":"270","author":"Wojcikiewicz","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.biolcel.2003.11.004","article-title":"Subcellular distribution of the inositol 1,4,5-trisphosphate receptors: functional relevance and molecular determinants","volume":"96","author":"Vermassen","year":"2004","journal-title":"Biol. Cell."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0065","doi-asserted-by":"crossref","first-page":"ra35","DOI":"10.1126\/scisignal.aad6281","article-title":"Defining the stoichiometry of inositol 1,4,5-trisphosphate binding required to initiate Ca2+ release","volume":"9","author":"Alzayady","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0070","doi-asserted-by":"crossref","first-page":"19700","DOI":"10.3390\/ijms151119700","article-title":"Cell-surface receptors transactivation mediated by G protein-coupled receptors","volume":"15","author":"Cattaneo","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0075","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","article-title":"Cell signaling by receptor tyrosine kinases","volume":"141","author":"Lemmon","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0080","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1471-4159.2007.04825.x","article-title":"IP3 receptor\/Ca2+ channel: from discovery to new signaling concepts","volume":"102","author":"Mikoshiba","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0085","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ceca.2014.08.002","article-title":"Toward a high-resolution structure of IP3R channel","volume":"56","author":"Serysheva","year":"2014","journal-title":"Cell Calcium"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bbamcr.2004.09.016","article-title":"Structural insights into the regulatory mechanism of IP3 receptor","volume":"1742","author":"Bosanac","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0095","doi-asserted-by":"crossref","first-page":"12755","DOI":"10.1074\/jbc.M609833200","article-title":"Molecular basis of the isoform-specific ligand-binding affinity of inositol 1,4,5-trisphosphate receptors","volume":"282","author":"Iwai","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1042\/BJ20040072","article-title":"Thimerosal stimulates Ca2+ flux through inositol 1,4,5-trisphosphate receptor type 1, but not type 3, via modulation of an isoform-specific Ca2+-dependent intramolecular interaction","volume":"381","author":"Bultynck","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0105","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature15249","article-title":"Gating machinery of InsP3R channels revealed by electron cryomicroscopy","volume":"527","author":"Fan","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0110","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1073\/pnas.1701420114","article-title":"IP3-mediated gating mechanism of the IP3 receptor revealed by mutagenesis and X-ray crystallography","volume":"114","author":"Hamada","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0115","doi-asserted-by":"crossref","first-page":"16551","DOI":"10.1074\/jbc.M300646200","article-title":"Critical regions for activation gating of the inositol 1,4,5-trisphosphate receptor","volume":"278","author":"Uchida","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0120","doi-asserted-by":"crossref","first-page":"32941","DOI":"10.1074\/jbc.M113.496802","article-title":"Inositol 1,4,5-trisphosphate (IP3) receptor up-regulation in hypertension is associated with sensitization of Ca2+ release and vascular smooth muscle contractility","volume":"288","author":"Abou-Saleh","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0125","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1073\/pnas.96.10.5797","article-title":"Calcineurin controls inositol 1,4,5-trisphosphate type 1 receptor expression in neurons","volume":"96","author":"Genazzani","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0130","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1074\/jbc.M114.587030","article-title":"Post-translational regulation of the type III inositol 1,4,5-trisphosphate receptor by miRNA-506","volume":"290","author":"Ananthanarayanan","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0135","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature22965","article-title":"PTEN counteracts FBXL2 to promote IP3R3- and Ca2+-mediated apoptosis limiting tumour growth","volume":"546","author":"Kuchay","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0140","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature22798","article-title":"BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation","volume":"546","author":"Bononi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0145","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1042\/bj3390453","article-title":"Down-regulation of types I, II and III inositol 1,4,5-trisphosphate receptors is mediated by the ubiquitin\/proteasome pathway","volume":"339","author":"Oberdorf","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0150","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ceca.2009.05.002","article-title":"When worlds collide: IP3 receptors and the ERAD pathway","volume":"46","author":"Wojcikiewicz","year":"2009","journal-title":"Cell Calcium"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0155","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1152\/physrev.00035.2006","article-title":"Inositol trisphosphate receptor Ca2+ release channels","volume":"87","author":"Foskett","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0160","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.bbamcr.2008.12.003","article-title":"Regulation of inositol 1,4,5-trisphosphate receptor-induced Ca2+ release by reversible phosphorylation and dephosphorylation","volume":"1793","author":"Vanderheyden","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0165","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1113\/JP271139","article-title":"Inositol 1,4,5-trisphosphate receptors and their protein partners as signalling hubs","volume":"594","author":"Prole","year":"2016","journal-title":"J. Physiol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0170","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.bbamcr.2016.01.002","article-title":"ER functions of oncogenes and tumor suppressors: modulators of intracellular Ca2+ signaling","volume":"1863 (","author":"Bittremieux","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0175","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.molcel.2006.05.017","article-title":"IRBIT suppresses IP3 receptor activity by competing with IP3 for the common binding site on the IP3 receptor","volume":"22","author":"Ando","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0180","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1042\/BJ20070361","article-title":"Protein phosphatase-1 is a novel regulator of the interaction between IRBIT and the inositol 1,4,5-trisphosphate receptor","volume":"407","author":"Devogelaere","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0185","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1042\/bj3080083","article-title":"The calmodulin-binding domain in the mouse type 1 inositol 1,4,5-trisphosphate receptor","volume":"308","author":"Yamada","year":"1995","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0190","doi-asserted-by":"crossref","first-page":"11627","DOI":"10.1073\/pnas.94.21.11627","article-title":"Ca2+-independent inhibition of inositol trisphosphate receptors by calmodulin: redistribution of calmodulin as a possible means of regulating Ca2+ mobilization","volume":"94","author":"Patel","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0195","doi-asserted-by":"crossref","first-page":"13748","DOI":"10.1074\/jbc.274.20.13748","article-title":"The bell-shaped Ca2+ dependence of the inositol 1,4, 5-trisphosphate-induced Ca2+ release is modulated by Ca2+\/calmodulin","volume":"274","author":"Missiaen","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0200","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0896-6273(01)80037-4","article-title":"Calmodulin mediates calcium-dependent inactivation of the cerebellar type 1 inositol 1,4,5-trisphosphate receptor","volume":"23","author":"Michikawa","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0205","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1042\/bj20020144","article-title":"Localization and function of a calmodulin-apocalmodulin-binding domain in the N-terminal part of the type 1 inositol 1,4,5-trisphosphate receptor","volume":"365","author":"Sienaert","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0210","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1073\/pnas.102006299","article-title":"Identification of a family of calcium sensors as protein ligands of inositol trisphosphate receptor Ca2+ release channels","volume":"99","author":"Yang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0215","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1074\/jbc.M309617200","article-title":"Calcium-binding protein 1 is an inhibitor of agonist-evoked, inositol 1,4,5-trisphosphate-mediated calcium signaling","volume":"279","author":"Haynes","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0220","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/sj.emboj.7600037","article-title":"Regulation of InsP3 receptor activity by neuronal Ca2+-binding proteins","volume":"23","author":"Kasri","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0225","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1042\/bj20030110","article-title":"Carbonic anhydrase-related protein is a novel binding protein for inositol 1,4,5-trisphosphate receptor type 1","volume":"372","author":"Hirota","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118273","article-title":"Carbonic anhydrase-8 regulates inflammatory pain by inhibiting the ITPR1-cytosolic free calcium pathway","volume":"10","author":"Zhuang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0235","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1083\/jcb.200309146","article-title":"Bcl-2 functionally interacts with inositol 1,4,5-trisphosphate receptors to regulate calcium release from the ER in response to inositol 1,4,5-trisphosphate","volume":"166","author":"Chen","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0240","doi-asserted-by":"crossref","first-page":"14397","DOI":"10.1073\/pnas.0907555106","article-title":"The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor","volume":"106","author":"Rong","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0245","doi-asserted-by":"crossref","first-page":"13678","DOI":"10.1074\/jbc.M109.096040","article-title":"Apoptosis protection by Mcl-1 and Bcl-2 modulation of inositol 1,4,5-trisphosphate receptor-dependent Ca2+ signaling","volume":"285","author":"Eckenrode","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0250","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/ncb1302","article-title":"The endoplasmic reticulum gateway to apoptosis by Bcl-XL modulation of the InsP3R","volume":"7","author":"White","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0255","article-title":"RCN1 suppresses ER stress-induced apoptosis via calcium homeostasis and PERK-CHOP signaling","volume":"6","author":"Xu","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0260","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/cdd.2009.34","article-title":"The inositol 1,4,5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1","volume":"16","author":"Vicencio","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0265","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.4161\/auto.7.12.17909","article-title":"Ins(1,4,5)P3 receptor-mediated Ca2+ signaling and autophagy induction are interrelated","volume":"7","author":"Decuypere","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0270","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cell.2004.11.048","article-title":"Subtype-specific and ER lumenal environment-dependent regulation of inositol 1,4,5-trisphosphate receptor type 1 by ERp44","volume":"120","author":"Higo","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0275","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.neuron.2010.11.010","article-title":"Mechanism of ER stress-induced brain damage by IP3 receptor","volume":"68","author":"Higo","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0280","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1073\/pnas.98.2.491","article-title":"Regulating ankyrin dynamics: roles of sigma-1 receptors","volume":"98","author":"Hayashi","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0285","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/ncb1063","article-title":"Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis","volume":"5","author":"Boehning","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0290","doi-asserted-by":"crossref","first-page":"11820","DOI":"10.1074\/jbc.M115.711242","article-title":"The stability and expression level of Bok are governed by binding to inositol 1,4,5-trisphosphate receptors","volume":"291","author":"Schulman","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0295","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.neuron.2008.04.015","article-title":"Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating","volume":"58","author":"Cheung","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0300","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0896-6273(03)00366-0","article-title":"Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1","volume":"39","author":"Tang","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0305","doi-asserted-by":"crossref","first-page":"9148","DOI":"10.1523\/JNEUROSCI.0660-09.2009","article-title":"Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2","volume":"29","author":"Liu","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0310","doi-asserted-by":"crossref","first-page":"12713","DOI":"10.1523\/JNEUROSCI.3909-08.2008","article-title":"Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 3","volume":"28","author":"Chen","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0315","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.bbamcr.2014.12.006","article-title":"The type 2 inositol 1,4,5-trisphosphate receptor, emerging functions for an intriguing Ca2+-release channel","volume":"1853","author":"Vervloessem","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0320","doi-asserted-by":"crossref","first-page":"37225","DOI":"10.1074\/jbc.M705641200","article-title":"Abnormal taste perception in mice lacking the type 3 inositol 1,4,5-trisphosphate receptor","volume":"282","author":"Hisatsune","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0325","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1038\/jid.2012.141","article-title":"Regulation of hair shedding by the type 3 IP3 receptor","volume":"132","author":"Sato-Miyaoka","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0330","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1126\/science.1114110","article-title":"IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism","volume":"309","author":"Futatsugi","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0335","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1471-4159.2008.05221.x","article-title":"Type 2 and type 3 inositol 1,4,5-trisphosphate (IP3) receptors promote the differentiation of granule cell precursors in the postnatal cerebellum","volume":"105","author":"Futatsugi","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0340","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1111\/j.1460-9568.2008.06240.x","article-title":"Decreased olfactory mucus secretion and nasal abnormality in mice lacking type 2 and type 3 IP3 receptors","volume":"27","author":"Fukuda","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099205","article-title":"Mice lacking inositol 1,4,5-trisphosphate receptors exhibit dry eye","volume":"9","author":"Inaba","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0350","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/379168a0","article-title":"Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor","volume":"379","author":"Matsumoto","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012500","article-title":"Gene knock-outs of inositol 1,4,5-trisphosphate receptors types 1 and 2 result in perturbation of cardiogenesis","volume":"5","author":"Uchida","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0360","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1152\/physrev.00006.2016","article-title":"The inositol trisphosphate\/calcium signaling pathway in health and disease","volume":"96","author":"Berridge","year":"2016","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0365","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/j.bbamcr.2014.04.017","article-title":"A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum","volume":"1843","author":"Akl","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0370","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ceca.2016.04.005","article-title":"Intracellular Ca2+ signaling and Ca2+ microdomains in the control of cell survival, apoptosis and autophagy","volume":"60","author":"La Rovere","year":"2016","journal-title":"Cell Calcium"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0375","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jbior.2017.12.001","article-title":"Remodeling of Ca2+ signaling in cancer: regulation of inositol 1,4,5-trisphosphate receptors through oncogenes and tumor suppressors","volume":"68","author":"Ando","year":"2018","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0380","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fonc.2017.00140","article-title":"IP3 receptor-mediated calcium signaling and its role in autophagy in cancer","volume":"7","author":"Kania","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0385","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/jnc.13991","article-title":"IP3 receptor mutations and brain diseases in human and rodents","volume":"141","author":"Hisatsune","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0390","doi-asserted-by":"crossref","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","article-title":"ClinVar: public archive of relationships among sequence variation and human phenotype","volume":"42","author":"Landrum","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0395","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0400","first-page":"11","article-title":"Widespread expression of inositol 1,4,5-trisphosphate receptor type 1 gene (InsP3R1) in the mouse central nervous system","volume":"1","author":"Furuichi","year":"1993","journal-title":"Recept. Channels"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0405","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1212\/WNL.57.10.1913","article-title":"A new autosomal dominant pure cerebellar ataxia","volume":"57","author":"Storey","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0410","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1371\/journal.pgen.0030108","article-title":"Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humans","volume":"3","author":"van de Leemput","year":"2007","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0415","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1523\/JNEUROSCI.17-02-00635.1997","article-title":"The type 1 inositol 1,4,5-trisphosphate receptor gene is altered in the opisthotonos mouse","volume":"17","author":"Street","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0420","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0969-9961(03)00029-9","article-title":"Spinocerebellar ataxia type 15 (SCA15) maps to 3p24.2-3pter: exclusion of the ITPR1 gene, the human orthologue of an ataxic mouse mutant","volume":"13","author":"Knight","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0425","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/jmg.2007.053942","article-title":"Heterozygous deletion of ITPR1, but not SUMF1, in spinocerebellar ataxia type 16","volume":"45","author":"Iwaki","year":"2008","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0430","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12311-009-0154-0","article-title":"Two Italian families with ITPR1 gene deletion presenting a broader phenotype of SCA15","volume":"9","author":"Di Gregorio","year":"2010","journal-title":"Cerebellum"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0435","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1373\/clinchem.2009.124958","article-title":"Development of a multiplex ligation-dependent probe amplification assay for diagnosis and estimation of the frequency of spinocerebellar ataxia type 15","volume":"55","author":"Ganesamoorthy","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0440","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1212\/01.wnl.0000311277.71046.a0","article-title":"Total deletion and a missense mutation of ITPR1 in Japanese SCA15 families","volume":"71","author":"Hara","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0445","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1002\/mds.23223","article-title":"An ITPR1 gene deletion causes spinocerebellar ataxia 15\/16: a genetic, clinical and radiological description","volume":"25","author":"Novak","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0450","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/archneurol.2011.81","article-title":"SCA15 due to large ITPR1 deletions in a cohort of 333 white families with dominant ataxia","volume":"68","author":"Marelli","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0455","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/jmg.2007.056341","article-title":"\u201cSCA16\u201d is really SCA15","volume":"45","author":"Gardner","year":"2008","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0460","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.bbrc.2011.06.043","article-title":"Functional characterization of the P1059L mutation in the inositol 1,4,5-trisphosphate receptor type 1 identified in a Japanese SCA15 family","volume":"410","author":"Yamazaki","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0465","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/mds.22970","article-title":"Sequencing analysis of the ITPR1 gene in a pure autosomal dominant spinocerebellar ataxia series","volume":"25","author":"van de Leemput","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0470","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/S0006-3495(02)75548-3","article-title":"Functional characterization of the type 1 inositol 1,4,5-trisphosphate receptor coupling domain SII(+\/\u2212) splice variants and the Opisthotonos mutant form","volume":"82","author":"Tu","year":"2002","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0475","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1752-0509-6-70","article-title":"Computational analysis of calcium signaling and membrane electrophysiology in cerebellar Purkinje neurons associated with ataxia","volume":"6","author":"Brown","year":"2012","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0480","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1523\/JNEUROSCI.23-02-00403.2003","article-title":"Modulation of type 1 inositol (1,4,5)-trisphosphate receptor function by protein kinase A and protein phosphatase 1\u03b1","volume":"23","author":"Tang","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0485","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00335-014-9547-6","article-title":"Spinocerebellar ataxia in the Italian Spinone dog is associated with an intronic GAA repeat expansion in ITPR1","volume":"26","author":"Forman","year":"2015","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0490","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","article-title":"Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion","volume":"271","author":"Campuzano","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0495","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1212\/01.WNL.0000147299.80872.D1","article-title":"Autosomal dominant congenital non-progressive ataxia overlaps with the SCA15 locus","volume":"63","author":"Dudding","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0500","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1750-1172-7-67","article-title":"Missense mutations in ITPR1 cause autosomal dominant congenital nonprogressive spinocerebellar ataxia","volume":"7","author":"Huang","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0505","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10048-013-0375-8","article-title":"Diagnostic utility of whole exome sequencing in patients showing cerebellar and\/or vermis atrophy in childhood","volume":"14","author":"Ohba","year":"2013","journal-title":"Neurogenetics"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0510","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jamaneurol.2014.1944","article-title":"Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia","volume":"71","author":"Fogel","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0515","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13023-017-0672-7","article-title":"Spinocerebellar ataxia type 29 due to mutations in ITPR1: a case series and review of this emerging congenital ataxia","volume":"12","author":"Zambonin","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0520","first-page":"2","article-title":"ITPR1 gene p.Val1553Met mutation in Russian family with mild spinocerebellar ataxia","volume":"3","author":"Shadrina","year":"2016"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0525","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/cge.12783","article-title":"Mutations in the IRBIT domain of ITPR1 are a frequent cause of autosomal dominant nonprogressive congenital ataxia","volume":"91","author":"Barresi","year":"2017","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0530","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1007\/s00415-015-7705-8","article-title":"Sporadic infantile-onset spinocerebellar ataxia caused by missense mutations of the inositol 1,4,5-triphosphate receptor type 1 gene","volume":"262","author":"Sasaki","year":"2015","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0535","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1093\/brain\/awv117","article-title":"De novo point mutations in patients diagnosed with ataxic cerebral palsy","volume":"138","author":"Parolin Schnekenberg","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0540","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.pjnns.2017.06.012","article-title":"Missense mutation in the ITPR1 gene presenting with ataxic cerebral palsy: description of an affected family and literature review","volume":"51","author":"Das","year":"2017","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0545","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.celrep.2015.07.023","article-title":"Exome sequence analysis suggests that genetic burden contributes to phenotypic variability and complex neuropathy","volume":"12","author":"Gonzaga-Jauregui","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0550","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187503","article-title":"Mutational analysis of ITPR1 in a Taiwanese cohort with cerebellar ataxias","volume":"12","author":"Hsiao","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0555","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1007\/s00415-017-8545-5","article-title":"A novel gain-of-function mutation in the ITPR1 suppressor domain causes spinocerebellar ataxia with altered Ca2+ signal patterns","volume":"264","author":"Casey","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0560","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s12311-017-0896-z","article-title":"Identification of a splicing mutation in ITPR1 via WES in a Chinese early-onset spinocerebellar ataxia family","volume":"17","author":"Wang","year":"2018","journal-title":"Cerebellum"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0565","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/ejhg.2017.54","article-title":"A missense variant in ITPR1 provides evidence for autosomal recessive SCA29 with asymptomatic cerebellar hypoplasia in carriers","volume":"25","author":"Klar","year":"2017","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0570","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/archopht.1965.00970030340008","article-title":"Aniridia, cerebellar ataxia, and oligophrenia in siblings","volume":"73","author":"Gillespie","year":"1965","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0575","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/jmg.16.5.373","article-title":"Non-progressive cerebellar ataxia, aplasia of pupillary zone of iris, and mental subnormality (Gillespie's syndrome) affecting 3 members of a non-consanguineous family in 2 generations","volume":"16","author":"Crawfurd","year":"1979","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0580","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/13816818409009891","article-title":"Gillespie's syndrome (incomplete aniridia, cerebellar ataxia and oligophrenia)","volume":"4","author":"Francois","year":"1984","journal-title":"Ophthalmic Paediatr. Genet."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0585","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ajhg.2016.03.018","article-title":"A restricted repertoire of de novo mutations in ITPR1 cause Gillespie syndrome with evidence for dominant-negative effect","volume":"98","author":"McEntagart","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0590","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.ajhg.2016.03.004","article-title":"Recessive and dominant de novo ITPR1 mutations cause Gillespie syndrome","volume":"98","author":"Gerber","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0595","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1126\/science.1125203","article-title":"Ca2+ entry through plasma membrane IP3 receptors","volume":"313","author":"Dellis","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0600","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1074\/jbc.M706645200","article-title":"Molecular characterization of the inositol 1,4,5-trisphosphate receptor pore-forming segment","volume":"283","author":"Schug","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0605","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.gene.2017.07.017","article-title":"Identification of novel and hotspot mutations in the channel domain of ITPR1 in two patients with Gillespie syndrome","volume":"628","author":"Dentici","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0610","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ajmg.a.37962","article-title":"A de novo missense mutation in the inositol 1,4,5-triphosphate receptor type 1 gene causing severe pontine and cerebellar hypoplasia: expanding the phenotype of ITPR1-related spinocerebellar ataxia's","volume":"173","author":"van Dijk","year":"2017","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0615","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejmg.2017.11.005","article-title":"Additional features of Gillespie syndrome in two Brazilian siblings with a novel ITPR1 homozygous pathogenic variant","volume":"61","author":"Carvalho","year":"2018","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0620","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/WNO.0000000000000090","article-title":"Congenital fixed dilated pupils due to ACTA2-multisystemic smooth muscle dysfunction syndrome","volume":"34","author":"Roulez","year":"2014","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0625","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fped.2015.00067","article-title":"Clinical impact and cost-effectiveness of whole exome sequencing as a diagnostic tool: a pediatric center's experience","volume":"3","author":"Valencia","year":"2015","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181791","article-title":"Comprehensive investigation of CASK mutations and other genetic etiologies in 41 patients with intellectual disability and microcephaly with pontine and cerebellar hypoplasia (MICPCH)","volume":"12","author":"Hayashi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0635","article-title":"Inositol 1,4,5-trisphosphate receptors and neurodegenerative disorders","author":"Egorova","year":"2017","journal-title":"FEBS J."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2018.05.009","article-title":"Ca2+ signaling and spinocerebellar ataxia","author":"Hisatsune","year":"2018","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0645","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1534\/genetics.105.044487","article-title":"Carbonic anhydrase-related protein VIII deficiency is associated with a distinctive lifelong gait disorder in waddles mice","volume":"171","author":"Jiao","year":"2005","journal-title":"Genetics"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0650","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ng1196-277","article-title":"Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT","volume":"14","author":"Sanpei","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0655","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ng1196-285","article-title":"Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG\/glutamine repeats","volume":"14","author":"Imbert","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0660","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng1196-269","article-title":"Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2","volume":"14","author":"Pulst","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0665","doi-asserted-by":"crossref","first-page":"12786","DOI":"10.1523\/JNEUROSCI.1643-12.2012","article-title":"Chronic suppression of inositol 1,4,5-triphosphate receptor-mediated calcium signaling in cerebellar purkinje cells alleviates pathological phenotype in spinocerebellar ataxia 2 mice","volume":"32","author":"Kasumu","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0670","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.tibs.2013.05.003","article-title":"Huntington's disease: underlying molecular mechanisms and emerging concepts","volume":"38","author":"Labbadia","year":"2013","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0675","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007476","article-title":"Huntington's disease","volume":"3","author":"Finkbeiner","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0680","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2047-9158-2-15","article-title":"Biological function of Presenilin and its role in AD pathogenesis","volume":"2","author":"Zhang","year":"2013","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0685","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004529","article-title":"Analyzing and quantifying the gain-of-function enhancement of IP3 receptor gating by familial Alzheimer's disease-causing mutants in presenilins","volume":"11","author":"Mak","year":"2015","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0690","doi-asserted-by":"crossref","first-page":"ra22","DOI":"10.1126\/scisignal.2000818","article-title":"Gain-of-function enhancement of IP3 receptor modal gating by familial Alzheimer's disease-linked presenilin mutants in human cells and mouse neurons","volume":"3","author":"Cheung","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0695","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ceca.2016.05.002","article-title":"The gain-of-function enhancement of IP3-receptor channel gating by familial Alzheimer's disease-linked presenilin mutants increases the open probability of mitochondrial permeability transition pore","volume":"60","author":"Toglia","year":"2016","journal-title":"Cell Calcium"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0700","doi-asserted-by":"crossref","first-page":"13293","DOI":"10.1073\/pnas.1109297108","article-title":"Constitutive cAMP response element binding protein (CREB) activation by Alzheimer's disease presenilin-driven inositol trisphosphate receptor (InsP3R) Ca2+ signaling","volume":"108","author":"M\u00fcller","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0705","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1523\/JNEUROSCI.5441-13.2014","article-title":"Suppression of InsP3 receptor-mediated Ca2+ signaling alleviates mutant presenilin-linked familial Alzheimer's disease pathogenesis","volume":"34","author":"Shilling","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0710","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jid.2016.03.024","article-title":"Identification of gene mutations and fusion genes in patients with Sezary syndrome","volume":"136","author":"Prasad","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0715","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1200\/JCO.2010.32.0630","volume":"29","author":"Olsen","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0720","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.18632\/aging.100984","article-title":"ERP44 inhibits human lung cancer cell migration mainly via IP3R2","volume":"8","author":"Huang","year":"2016","journal-title":"Aging"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0725","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1158\/0008-5472.CAN-09-2886","article-title":"Caffeine-mediated inhibition of calcium release channel inositol 1,4,5-trisphosphate receptor subtype 3 blocks glioblastoma invasion and extends survival","volume":"70","author":"Kang","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0730","doi-asserted-by":"crossref","first-page":"72324","DOI":"10.18632\/oncotarget.20327","article-title":"Downregulation of type 3 inositol (1,4,5)-trisphosphate receptor decreases breast cancer cell migration through an oscillatory Ca2+ signal","volume":"8","author":"Mound","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0735","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ceca.2015.02.004","article-title":"Endoplasmic reticulum Ca2+ content decrease by PKA-dependent hyperphosphorylation of type 1 IP3 receptor contributes to prostate cancer cell resistance to androgen deprivation","volume":"57","author":"Boutin","year":"2015","journal-title":"Cell Calcium"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0740","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/sj.onc.1208313","article-title":"Inositol 1,4,5-trisphosphate (IP3) receptor type1 (IP3R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines","volume":"24","author":"Tsunoda","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0745","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.celrep.2016.02.030","article-title":"Selective vulnerability of cancer cells by inhibition of Ca2+ transfer from endoplasmic reticulum to mitochondria","volume":"14","author":"C\u00e1rdenas","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0750","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fonc.2017.00070","article-title":"Endoplasmic reticulum-mitochondrial Ca2+ fluxes underlying cancer cell survival","volume":"7","author":"Ivanova","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0755","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-981-10-4567-7_17","article-title":"Alterations in Ca2+ signalling via ER-mitochondria contact site remodelling in cancer","volume":"997","author":"Kerkhofs","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0760","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/978-3-319-57732-6_31","article-title":"Metabolic disorders and cancer: store-operated Ca2+ entry in cancer: focus on IP3R-mediated Ca2+ release from intracellular stores and its role in migration and invasion","volume":"993","author":"Ritaine","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0765","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1530\/JOE-11-0012","article-title":"Inositol 1,4,5-trisphosphate receptor 1 mutation perturbs glucose homeostasis and enhances susceptibility to diet-induced diabetes","volume":"210","author":"Ye","year":"2011","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0770","doi-asserted-by":"crossref","first-page":"13783","DOI":"10.1073\/pnas.96.24.13783","article-title":"Defects in inositol 1,4,5-trisphosphate receptor expression, Ca2+ signaling, and insulin secretion in the anx7(+\/\u2212) knockout mouse","volume":"96","author":"Srivastava","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0775","doi-asserted-by":"crossref","first-page":"45455","DOI":"10.1074\/jbc.M407673200","article-title":"Ca2+-induced Ca2+ release via inositol 1,4,5-trisphosphate receptors is amplified by protein kinase A and triggers exocytosis in pancreatic \u03b2-cells","volume":"279","author":"Dyachok","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0780","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1172\/JCI70720","article-title":"Abolished InsP3R2 function inhibits sweat secretion in both humans and mice","volume":"124","author":"Klar","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0785","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00002281-199509000-00008","article-title":"Sj\u00f6gren's syndrome","volume":"7","author":"Fox","year":"1995","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0790","doi-asserted-by":"crossref","first-page":"13953","DOI":"10.1038\/srep13953","article-title":"IP3R deficit underlies loss of salivary fluid secretion in Sj\u00f6gren's syndrome","volume":"5","author":"Teos","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0795","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/art.38898","article-title":"Genome-wide association study identifies ITPR2 as a susceptibility gene for Kashin-Beck disease in Han Chinese","volume":"67","author":"Zhang","year":"2015","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0800","first-page":"615","article-title":"Chondrocyte apoptosis and expression of Bcl-2, Bax, Fas, and iNOS in articular cartilage in patients with Kashin-Beck disease","volume":"33","author":"Wang","year":"2006","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0805","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0024-3205(99)00405-1","article-title":"Calcium handling proteins in isolated spinal motoneurons","volume":"65","author":"Van Den Bosch","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0810","doi-asserted-by":"crossref","first-page":"28613","DOI":"10.1016\/S0021-9258(19)61949-6","article-title":"Co-expression in vertebrate tissues and cell lines of multiple inositol 1,4,5-trisphosphate (InsP3) receptors with distinct affinities for InsP3","volume":"269","author":"Newton","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0815","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S1474-4422(07)70222-3","article-title":"ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study","volume":"6","author":"van Es","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0820","doi-asserted-by":"crossref","first-page":"551.e1","DOI":"10.1016\/j.neurobiolaging.2009.04.018","article-title":"No evidence of association of FLJ10986 and ITPR2 with ALS in a large German cohort","volume":"32","author":"Fernandez-Santiago","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0825","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1093\/hmg\/ddp059","article-title":"A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis","volume":"18","author":"Chio","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0830","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1093\/hmg\/ddw190","article-title":"Genetic ablation of IP3 receptor 2 increases cytokines and decreases survival of SOD1G93A mice","volume":"25","author":"Staats","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0835","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1096\/fasebj.14.10.1375","article-title":"Type 3 inositol 1,4,5-trisphosphate receptor modulates cell death","volume":"14","author":"Blackshaw","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0840","doi-asserted-by":"crossref","first-page":"R933","DOI":"10.1016\/j.cub.2004.10.019","article-title":"Cell signalling: IP3 receptors channel calcium into cell death","volume":"14","author":"Hanson","year":"2004","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0845","doi-asserted-by":"crossref","first-page":"40892","DOI":"10.1074\/jbc.M506623200","article-title":"The type III inositol 1,4,5-trisphosphate receptor preferentially transmits apoptotic Ca2+ signals into mitochondria","volume":"280","author":"Mendes","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0850","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1476-4598-9-156","article-title":"Inositol 1,4,5-trisphosphate-induced Ca2+ signalling is involved in estradiol-induced breast cancer epithelial cell growth","volume":"9","author":"Szatkowski","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0855","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ceca.2010.09.005","article-title":"The type III inositol 1,4,5-trisphosphate receptor is associated with aggressiveness of colorectal carcinoma","volume":"48","author":"Shibao","year":"2010","journal-title":"Cell Calcium"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0860","first-page":"3691","article-title":"Possible involvement of inositol 1,4,5-trisphosphate receptor type 3 (IP3R3) in the peritoneal dissemination of gastric cancers","volume":"23","author":"Sakakura","year":"2003","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0865","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1172\/JCI82066","article-title":"Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma","volume":"126","author":"Hedberg","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0870","doi-asserted-by":"crossref","first-page":"10085","DOI":"10.18632\/oncotarget.14341","article-title":"ITPR3 gene haplotype is associated with cervical squamous cell carcinoma risk in Taiwanese women","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0875","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10038-007-0233-3","article-title":"A functional SNP in the NKX2.5-binding site of ITPR3 promoter is associated with susceptibility to systemic lupus erythematosus in Japanese population","volume":"53","author":"Oishi","year":"2008","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0880","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1086\/507876","article-title":"Genetic mapping at 3-kilobase resolution reveals inositol 1,4,5-triphosphate receptor 3 as a risk factor for type 1 diabetes in Sweden","volume":"79","author":"Roach","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0885","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1744-313X.2010.00943.x","article-title":"Single nucleotide polymorphism rs2229634 in the ITPR3 gene is associated with the risk of developing coronary artery aneurysm in children with Kawasaki disease","volume":"37","author":"Huang","year":"2010","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0890","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ceca.2018.01.002","article-title":"A critical appraisal of the role of intracellular Ca2+-signaling pathways in Kawasaki disease","volume":"71","author":"Bijnens","year":"2018","journal-title":"Cell Calcium"},{"key":"10.1016\/j.bbamcr.2018.06.004_bb0895","series-title":"Messenger","article-title":"Inositol 1,4,5-trisphosphate receptor mutations associated with human disease","author":"Terry","year":"2018"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488918301320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488918301320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T15:56:39Z","timestamp":1661442999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488918301320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":179,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0167488918301320"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2018.06.004","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathophysiological consequences of isoform-specific IP3 receptor mutations","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2018.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}